Replies to post #809 on Fate Therapeutics Inc (FATE)

[NY1972]

Invivo CART is worse than CARNK IMO, no sign of kidney recovery.
Within hours of administration, Chen and colleagues said, patients' B-cell counts declined sharply with the lower dose, and fell to zero with 4 mg.
So B cells are depleted in PB, just not the germinal centers, same issue facing ALLO